ERV asks: What happens when a PI holding an NIH grant dies, given that PIs support post-docs, graduate students, and technicians in his or her lab? In other words: Or what would happen to me if Bossman got hit by a bus or got brain cancer. Does the NIH have some sort of protocol for […]
Category: Clinical trials
I hate it when I fall behind in my journal reading. Of course, it happens all the time, as you might expect, with my time sandwiched between running my lab, writing grants, seeing patients, and operating. Sometimes, though, I get a chance to try to catch up a bit. Such was the case the other […]
Share this:
I realize that I’ve been very, very remiss in attending to a task that I’ve been meaning to get to since late January. There are several reasons, albeit not excuses, for why I have failed to do this task. Perhaps the most powerful impediment to my overcoming my inertia and just diving in and doing […]
Share this:
Perhaps one of the most common misconceptions held about cancer among lay people is that it is one disease. We often hear non-physicians talk about “curing cancer” as though it were a single disease. Sometimes, we even hear physicians, who should know better, using the same sort of fuzzy thinking and language about “curing cancer” […]
Share this:
Regular readers here are probably most familiar with the so-called “complementary and alternative medicine” therapy known as chelation therapy in the context of its use, or, more specifically, its misuse in “treating” autistic children, a misuse that has resulted in at least one death, a five-year-old autistic boy named Abubakar Tariq Nadama. However, before the […]
